Congress
The meeting will highlight cutting-edge science from immunology and cardiology and provide insight into recent developments towards therapeutic targeting of cardiac inflammation.
Activation and regulation of immune cells in the heart muscle and the pericardium are now recognized as key processes in cardiac diseases. Understanding and targeting the interaction of innate and adaptive immune cells with cardiomyocytes and cardiac stromal cells bears the potential to guide the development of future therapies for cardiomyopathy and heart failure patients. Cardioimmunology Zurich 2022 will highlight cutting-edge science from the fields of immunology and cardiology and provide insight into recent developments towards therapeutic targeting of cardiac inflammation.
https://cardioimmunology-zurich.ch/
SSAI – Swiss Society of Allergology and Immunology Registration Grant